Organon (NYSE: OGN)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.300 | 1.650 | 0.3500 | ||||
REV | 1.520B | 1.567B | 47.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Organon (NYSE: OGN) through any online brokerage.
Other companies in Organon’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Organon (NYSE: OGN) was reported by Goldman Sachs on Wednesday, April 27, 2022. The analyst firm set a price target for 40.00 expecting OGN to rise to within 12 months (a possible 6.07% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Organon (NYSE: OGN) is $37.71 last updated May 20, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.28 per share of Class A Common Stock. The quarterly cash dividend was payable on June 16, 2022 to stockholders of record on May 13, 2022.
Organon’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Organon.
Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.